Tags

Type your tag names separated by a space and hit enter

Acromegaly: an endocrine society clinical practice guideline.
J Clin Endocrinol Metab. 2014 Nov; 99(11):3933-51.JC

Abstract

OBJECTIVE

The aim was to formulate clinical practice guidelines for acromegaly.

PARTICIPANTS

The Task Force included a chair selected by the Endocrine Society Clinical Guidelines Subcommittee (CGS), five experts in the field, and a methodologist. The authors received no corporate funding or remuneration. This guideline is cosponsored by the European Society of Endocrinology.

EVIDENCE

This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence. The Task Force reviewed primary evidence and commissioned two additional systematic reviews.

CONSENSUS PROCESS

One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society and the European Society of Endocrinology reviewed drafts of the guidelines.

CONCLUSIONS

Using an evidence-based approach, this acromegaly guideline addresses important clinical issues regarding the evaluation and management of acromegaly, including the appropriate biochemical assessment, a therapeutic algorithm, including use of medical monotherapy or combination therapy, and management during pregnancy.

Authors+Show Affiliations

Stanford University School of Medicine (L.K.), Stanford, California 94305; Brigham and Women's Hospital (E.R.L), Boston, Massachusetts 02115; Cedars-Sinai Medical Center (S.M.), Los Angeles, California 90048; Northwestern University Feinberg School of Medicine (M.E.M), Chicago, Illinois 60611; Mayo Clinic (M.H.M.), Rochester, Minnesota 55905; Vanderbilt University (A.U.), Nashville, Tennessee 37232; and Oxford Centre Diabetes, Endocrinology, and Metabolism (J.A.H.W.), Churchill Hospital, Oxfordshire OX3 7RP, United Kingdom.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

25356808

Citation

Katznelson, Laurence, et al. "Acromegaly: an Endocrine Society Clinical Practice Guideline." The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 11, 2014, pp. 3933-51.
Katznelson L, Laws ER, Melmed S, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933-51.
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. (2014). Acromegaly: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 99(11), 3933-51. https://doi.org/10.1210/jc.2014-2700
Katznelson L, et al. Acromegaly: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014;99(11):3933-51. PubMed PMID: 25356808.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Acromegaly: an endocrine society clinical practice guideline. AU - Katznelson,Laurence, AU - Laws,Edward R,Jr AU - Melmed,Shlomo, AU - Molitch,Mark E, AU - Murad,Mohammad Hassan, AU - Utz,Andrea, AU - Wass,John A H, AU - ,, Y1 - 2014/10/30/ PY - 2014/10/31/entrez PY - 2014/10/31/pubmed PY - 2015/1/17/medline SP - 3933 EP - 51 JF - The Journal of clinical endocrinology and metabolism JO - J Clin Endocrinol Metab VL - 99 IS - 11 N2 - OBJECTIVE: The aim was to formulate clinical practice guidelines for acromegaly. PARTICIPANTS: The Task Force included a chair selected by the Endocrine Society Clinical Guidelines Subcommittee (CGS), five experts in the field, and a methodologist. The authors received no corporate funding or remuneration. This guideline is cosponsored by the European Society of Endocrinology. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence. The Task Force reviewed primary evidence and commissioned two additional systematic reviews. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society and the European Society of Endocrinology reviewed drafts of the guidelines. CONCLUSIONS: Using an evidence-based approach, this acromegaly guideline addresses important clinical issues regarding the evaluation and management of acromegaly, including the appropriate biochemical assessment, a therapeutic algorithm, including use of medical monotherapy or combination therapy, and management during pregnancy. SN - 1945-7197 UR - https://www.unboundmedicine.com/medline/citation/25356808/Acromegaly:_an_endocrine_society_clinical_practice_guideline_ L2 - https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2014-2700 DB - PRIME DP - Unbound Medicine ER -